Lancets Market by Type (Safety Lancets (Manually & Pressure activated), Standard Lancets, Application (Glucose Testing, Cholesterol Testing), Gauze Size (22G and Below), Age Group (Adult, Pediatrics), End Users (Hospitals), Region - Global Forecast to 2028

Abstract
The lancets market is projected to reach USD 3.6 Billion by 2028 from USD 2.3 Billion in 2023, at a CAGR of 9.7% during the forecast period. Growth in the lancets market is mainly driven by the growing prevalence of diabetes, the high prevalence of chronic diseases and the rising geriatric population. However, the risk of lancet-related needlestick injuries, the reuse of lancets, and Pricing pressure owing to reimbursement cuts and budget constraints are restricting the growth of this market.

“The Safety lancet segment accounted for the highest market share in the lancets systems market, by type, during the forecast period”

Based on the type of segment, the lancets system market is categorized into standard lancets and safety lancets. Safety lancet are sub categorized into Manually Activated and Automatically activated/Pressure activated. Push Button Lancets and Side Button Lancets Manually Activated are expected to the highest growth in the market which attributed to the growing geriatric population.

“Glucose Testing application accounted for the highest CAGR during the forecast period.”

Based on type, the application market is segmented into Glucose Testing, Hemoglobin Testing, Coagulation Testing, Cholesterol Testingm, Allergy Testing, Neonatal Screening and Other Applications. In 2022, the Glucose Testing dominated the market and the lancets market to observe the highest growth rate. Factors supporting the growth of the market is due to the growing prevalence of diabetes and increasing adoption of self-monitoring devices.

“The North America segment accounted for the highest market share in the lancets systems market, by region, during the forecast period”

Based on the region, the global lancets market is categorized into North America, Europe, Asia Pacific, and Rest of the world. North America is expected to witness high market share during the forecast period. Rising prevalence of various chronic diseases which is attributed to the demand of rising number of hospitals and surgical centers are also supporting the growth of the lancets market.

Breakdown of supply-side primary interviews, by company type, designation, and region:
• By Company Type: Tier 1 (32%), Tier 2 (46%), and Tier 3 (22%)
• By Designation: C-level (40%), Director-level (26%), and Others (32%)
• By Region: North America (35%), Asia- Pacific (21%), Europe (30%), Latin America (14%) and Middle East & Africa(3%)

Prominent companies include Becton, Dickinson and Company (US), F. Hoffmann-La Roche Ltd. (Switzerland), B. Braun SE (Germany), Abbott Laboratories (US), Greiner Bio-One International GmbH (Austria), Ypsomed (Switzerland), Terumo Corporation (Japan), Owen Mumford (UK), HTL-STREFA S.A. (Poland), ARKRAY, Inc. (Japan), SARSTEDT AG & Co. KG (Germany), SteriLance Medical (China), Medline Industries (US), AgaMatrix Holdings LLC (US), ACON Laboratories, Inc. (US), SANLI Medical & Health Service (China), Allison Medical Inc. (US), GlucoRx Limited (UK), FL Medical s.r.l. (Italy), A. Menarini Diagnostics s.r.l (Italy), CML Biotech (India), Neomedic (Spain), MHC Medical Products (US), and Disera Tıbbi Malzeme Lojistik Sanayi ve Ticaret A.S. (Turkey).

Research Coverage
This research report categorizes the lancets market by type (Safety and Standard lancets), by application (Glucose Testing, Hemoglobin Testing, Coagulation Testing, Cholesterol Testing, Allergy Testing, Neonatal Screening and Other Applications), by end user (Hospitals, Clinics and Ambulatory Surgery Centers, Homecare settings and Other end users (Diagnostic centers, Nursing Homes, Long Term Acute Care Centers, Emergency Medical Service Providers, and Academic Research Institutes), and region (North America, Europe, Asia Pacific and Rest of world). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the lancets market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, and services; key strategies; Contracts, partnerships, agreements. new product & service launches, mergers and acquisitions, and recent developments associated with the lancets market. Competitive analysis of upcoming startups in the Lancets market ecosystem is covered in this report.

Key Benefits of Buying the Report:
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall Lancets market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and to plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights on the following pointers:
•Analysis of key drivers (Growing prevalence of diabetes and increasing adoption of self-monitoring devices, Rising prevalence of various chronic diseases, Increasing demand for painless lancets, Growing geriatric population, Rising number of hospitals and surgical centers), restraints (Increasing incidence of lancet-related needlestick injuries and infections and Pricing pressure owing to reimbursement cuts and budget constraints) opportunities (Increasing incidence of lancet-related needlestick injuries and infections and Pricing pressure owing to reimbursement cuts and budget constraints), and challenges (Reuse of lancets) influencing the growth of the lancets market
•Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the Lancets market.
•Market Development: Comprehensive information about lucrative markets – the report analyses the lancets market across varied regions.
•Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the Lancets market
•Competitive Assessment: In-depth assessment of market shares, growth strategies and service offerings of leading players like Becton, Dickinson and Company (US), F. Hoffmann-La Roche Ltd. (Switzerland), B. Braun SE (Germany), Abbott Laboratories (US), and Greiner Bio-One International GmbH (Austria) and Terumo Corporation (Japan) among others in the lancets market strategies.

Content
Table of Contents

1INTRODUCTION28
1.1STUDY OBJECTIVES28
1.2MARKET DEFINITION28
1.2.1INCLUSIONS AND EXCLUSIONS29
1.3MARKET SCOPE30
1.3.1MARKETS COVERED30
FIGURE 1LANCETS MARKET SEGMENTATION30
1.3.2GEOGRAPHIC SCOPE30
1.3.3YEARS CONSIDERED31
1.4CURRENCY CONSIDERED31
1.5LIMITATIONS31
1.6MARKET STAKEHOLDERS32
1.7SUMMARY OF CHANGES32
2RESEARCH METHODOLOGY33
2.1RESEARCH DATA33
FIGURE 2RESEARCH DESIGN33
2.1.1SECONDARY DATA33
2.1.1.1Secondary sources35
2.1.2PRIMARY DATA35
FIGURE 3PRIMARY SOURCES35
2.1.2.1Key data from primary sources36
2.1.2.2Key industry insights37
2.1.2.3Breakdown of primary interviews37
FIGURE 4BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY- AND DEMAND- SIDE PARTICIPANTS37
FIGURE 5BREAKDOWN OF PRIMARY INTERVIEWS38
2.2MARKET SIZE ESTIMATION38
FIGURE 6REVENUE SHARE ANALYSIS ILLUSTRATION39
TABLE 1LANCETS MARKET: COUNTRY-LEVEL ANALYSIS (1/2)40
FIGURE 7LANCETS MARKET: COUNTRY-LEVEL ANALYSIS (2/2)41
2.2.1GROWTH FORECAST41
FIGURE 8CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS42
FIGURE 9TOP-DOWN APPROACH42
2.3MARKET BREAKDOWN AND DATA TRIANGULATION44
FIGURE 10DATA TRIANGULATION METHODOLOGY44
2.4MARKET SHARE ANALYSIS45
2.5ASSUMPTIONS45
2.6MARKET INDICATORS AND THEIR IMPACT46
2.7RISK ASSESSMENT46
TABLE 2RISK ASSESSMENT46
2.8IMPACT OF RECESSION: LANCETS MARKET47
3EXECUTIVE SUMMARY48
FIGURE 11LANCETS MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION)48
FIGURE 12LANCETS MARKET, BY GAUGE SIZE, 2023 VS. 2028 (USD MILLION)49
FIGURE 13LANCETS MARKET, BY AGE GROUP, 2023 VS. 2028 (USD MILLION)49
FIGURE 14LANCETS MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)50
FIGURE 15LANCETS MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)50
FIGURE 16GEOGRAPHICAL SNAPSHOT OF LANCETS MARKET51
4PREMIUM INSIGHTS52
4.1LANCETS MARKET OVERVIEW52
FIGURE 17INCREASING INCIDENCE OF DIABETES TO DRIVE MARKET52
4.2NORTH AMERICA: LANCETS MARKET, BY TYPE AND COUNTRY (2022)53
FIGURE 18SAFETY LANCETS HELD LARGEST SHARE OF NORTH AMERICAN MARKET IN 202253
4.3LANCETS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES54
FIGURE 19CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD54
5MARKET OVERVIEW55
5.1INTRODUCTION55
5.2MARKET DYNAMICS55
FIGURE 20LANCETS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES55
5.2.1DRIVERS56
5.2.1.1Growing prevalence of diabetes and increasing adoption of self-monitoring devices56
FIGURE 21INCIDENCE OF DIABETES, 2021 VS. 2045 (MILLION)56
5.2.1.2Rising prevalence of various chronic diseases57
FIGURE 22US: NUMBER OF PEOPLE WITH CHRONIC CONDITIONS, 1995–2030 (MILLION)57
5.2.1.3Increasing demand for painless lancets57
5.2.1.4Growing geriatric population58
TABLE 3GLOBAL GERIATRIC POPULATION, BY REGION, 2019 VS. 203058
5.2.1.5Rising number of hospitals and surgical centers59
5.2.2RESTRAINTS59
5.2.2.1Increasing incidence of lancet-related needlestick injuries and infections59
5.2.2.2Pricing pressure owing to reimbursement cuts and budget constraints60
5.2.3OPPORTUNITIES60
5.2.3.1High growth prospects in emerging countries60
5.2.3.2Increasing awareness of novel technologies61
5.2.4CHALLENGES61
5.2.4.1Reuse of lancets61
5.3VALUE CHAIN ANALYSIS61
FIGURE 23VALUE CHAIN ANALYSIS: MAJOR VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASES62
5.4SUPPLY CHAIN ANALYSIS62
FIGURE 24DIRECT DISTRIBUTION—PREFERRED STRATEGY FOR PROMINENT COMPANIES63
5.5PORTER’S FIVE FORCES ANALYSIS63
5.5.1THREAT OF NEW ENTRANTS63
5.5.2INTENSITY OF COMPETITIVE RIVALRY63
5.5.3BARGAINING POWER OF BUYERS64
5.5.4BARGAINING POWER OF SUPPLIERS64
5.5.5THREAT OF SUBSTITUTES64
5.6KEY STAKEHOLDERS AND BUYING CRITERIA64
5.6.1KEY STAKEHOLDERS IN BUYING PROCESS64
FIGURE 25INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR HOSPITALS, CLINICS, AND AMBULATORY SURGERY CENTERS64
TABLE 4INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP END USERS (%)64
5.6.2BUYING CRITERIA65
FIGURE 26KEY BUYING CRITERIA FOR HOSPITALS, CLINICS, AND AMBULATORY SURGERY CENTERS65
TABLE 5KEY BUYING CRITERIA FOR HOSPITALS, CLINICS, AND AMBULATORY SURGERY CENTERS65
5.7REGULATORY LANDSCAPE65
5.7.1NORTH AMERICA65
5.7.1.1US65
5.7.1.2Canada65
TABLE 6CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS66
5.7.2EUROPE66
5.7.3ASIA PACIFIC67
5.7.3.1Japan67
TABLE 7JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA67
5.7.3.2China67
TABLE 8CHINA: CLASSIFICATION OF MEDICAL DEVICES68
5.7.3.3India69
5.8TRADE ANALYSIS69
TABLE 9IMPORT DATA FOR HS CODE 901839, BY COUNTRY, 2018–2022 (USD MILLION)69
TABLE 10EXPORT DATA FOR HS CODE 901839, BY COUNTRY, 2018–2022 (USD MILLION)70
5.9ECOSYSTEM ANALYSIS70
TABLE 11ROLE IN ECOSYSTEM71
FIGURE 27KEY PLAYERS OPERATING IN LANCETS MARKET72
5.10PATENT ANALYSIS73
5.11KEY CONFERENCES AND EVENTS IN 2023–202474
TABLE 12LIST OF CONFERENCES AND EVENTS74
5.12PRICING ANALYSIS75
5.12.1AVERAGE SELLING PRICE OF KEY PRODUCTS75
TABLE 13PRICE RANGE OF KEY PRODUCTS IN THE LANCETS MARKET (USD)75
5.13TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES76
5.14TECHNOLOGY ANALYSIS76
6LANCETS MARKET, BY TYPE77
6.1INTRODUCTION78
FIGURE 28LANCETS MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION)78
TABLE 14LANCETS MARKET, BY TYPE, 2021–2028 (USD MILLION)78
6.2SAFETY LANCETS79
TABLE 15SAFETY LANCETS MARKET, BY TYPE, 2021–2028 (USD MILLION)79
TABLE 16SAFETY LANCETS MARKET, BY REGION, 2021–2028 (USD MILLION)79
6.2.1MANUALLY ACTIVATED LANCETS80
TABLE 17MANUALLY ACTIVATED LANCETS MARKET, BY TYPE, 2021–2028 (USD MILLION)80
TABLE 18MANUALLY ACTIVATED LANCETS MARKET, BY REGION, 2021–2028 (USD MILLION)80
6.2.1.1Side-button lancets80
6.2.1.1.1Anti-reuse measures to increase popularity among end users80
TABLE 19SIDE-BUTTON LANCETS MARKET, BY REGION, 2021–2028 (USD MILLION)81
6.2.1.2Push-button lancets81
6.2.1.2.1Ease of use and simplicity to drive demand81
TABLE 20PUSH-BUTTON LANCETS MARKET, BY REGION, 2021–2028 (USD MILLION)81
6.2.2AUTOMATICALLY ACTIVATED/PRESSURE-ACTIVATED LANCETS82
6.2.2.1Available in number of gauge sizes and penetration depths82
TABLE 21AUTOMATICALLY ACTIVATED/PRESSURE-ACTIVATED LANCETS MARKET, BY REGION, 2021–2028 (USD MILLION)82
6.3STANDARD LANCETS82
6.3.1INCREASING PREVALENCE OF DIABETES TO DRIVE ADOPTION82
TABLE 22STANDARD LANCETS MARKET, BY REGION, 2021–2028 (USD MILLION)83
7LANCETS MARKET, BY GAUGE SIZE84
7.1INTRODUCTION85
FIGURE 29LANCETS MARKET, BY GAUGE SIZE, 2023 VS. 2028 (USD MILLION)85
TABLE 23LANCETS MARKET, BY GAUGE SIZE, 2021–2028 (USD MILLION)86
7.222G AND BELOW86
7.2.1BENEFICIAL FOR MEDICAL TESTS THAT REQUIRE LARGER SAMPLE SIZE86
TABLE 2422G AND BELOW LANCETS MARKET, BY REGION, 2021–2028 (USD MILLION)86
7.323G–33G87
7.3.1WIDE AVAILABILITY OF 23G–33G LANCETS TO AID MARKET GROWTH87
TABLE 2523G–33G LANCETS MARKET, BY REGION, 2021–2028 (USD MILLION)87
7.4ABOVE 33G87
7.4.1LESS PAIN AND DISCOMFORT TO DRIVE ADOPTION87
TABLE 26ABOVE 33G LANCETS MARKET, BY REGION, 2021–2028 (USD MILLION)88
8LANCETS MARKET, BY AGE GROUP89
8.1INTRODUCTION90
FIGURE 30LANCETS MARKET, BY AGE GROUP, 2023 VS. 2028 (USD MILLION)90
TABLE 27LANCETS MARKET, BY AGE GROUP, 2021–2028 (USD MILLION)90
8.2ADULT90
8.2.1LARGEST AND FASTEST-GROWING SEGMENT90
TABLE 28ADULT LANCETS MARKET, BY REGION, 2021–2028 (USD MILLION)91
8.3PEDIATRIC91
8.3.1INCREASING PREVALENCE OF TYPE 1 DIABETES IN PEDIATRIC PATIENTS TO DRIVE MARKET91
TABLE 29PEDIATRIC LANCETS MARKET, BY REGION, 2021–2028 (USD MILLION)91
9LANCETS MARKET, BY APPLICATION92
9.1INTRODUCTION93
FIGURE 31LANCETS MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)93
TABLE 30LANCETS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)93
9.2GLUCOSE TESTING94
9.2.1RISING PREVALENCE OF DIABETES TO DRIVE MARKET94
TABLE 31LANCETS MARKET FOR GLUCOSE TESTING, BY REGION, 2021–2028 (USD MILLION)94
9.3HEMOGLOBIN TESTING95
9.3.1HIGH PREVALENCE OF ANEMIA TO DRIVE DEMAND95
TABLE 32LANCETS MARKET FOR HEMOGLOBIN TESTING, BY REGION, 2021–2028 (USD MILLION)95
9.4COAGULATION TESTING95
9.4.1RISING PREVALENCE OF LIVER DISEASES, THROMBOPHILIA, AND HEMOPHILIA TO DRIVE MARKET95
TABLE 33LANCETS MARKET FOR COAGULATION TESTING, BY REGION, 2021–2028 (USD MILLION)96
9.5CHOLESTEROL TESTING96
9.5.1RISING DEMAND FOR CHOLESTEROL HOME TEST KITS TO SUPPORT MARKET GROWTH96
TABLE 34LANCETS MARKET FOR CHOLESTEROL TESTING, BY REGION, 2021–2028 (USD MILLION)97
9.6ALLERGY TESTING97
9.6.1HIGH DEMAND FOR SPT TO PROPEL MARKET97
TABLE 35LANCETS MARKET FOR ALLERGY TESTING, BY REGION, 2021–2028 (USD MILLION)98
9.7NEONATAL SCREENING98
9.7.1GROWING NEED FOR DRY BLOOD SPOT TESTS TO DRIVE MARKET98
TABLE 36LANCETS MARKET FOR NEONATAL SCREENING, BY REGION, 2021–2028 (USD MILLION)99
9.8OTHER APPLICATIONS99
TABLE 37LANCETS MARKET FOR OTHER APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)100
10LANCETS MARKET, BY END USER101
10.1INTRODUCTION102
FIGURE 32LANCETS MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)102
TABLE 38LANCETS MARKET, BY END USER, 2021–2028 (USD MILLION)102
10.2HOSPITALS, CLINICS, AND AMBULATORY SURGERY CENTERS103
10.2.1INCREASING INCIDENCE OF CHRONIC DISEASES TO DRIVE ADOPTION OF LANCETS103
TABLE 39LANCETS MARKET FOR HOSPITALS, CLINICS, AND AMBULATORY SURGERY CENTERS, BY REGION, 2021–2028 (USD MILLION)104
10.3HOME CARE SETTINGS104
10.3.1TECHNOLOGICAL ADVANCEMENTS IN SELF/HOME CARE GLUCOSE MONITORING SYSTEMS TO DRIVE MARKET104
TABLE 40LANCETS MARKET FOR HOME CARE SETTINGS, BY REGION, 2021–2028 (USD MILLION)104
10.4OTHER END USERS105
TABLE 41LANCETS MARKET FOR OTHER END USERS, BY REGION, 2021–2028 (USD MILLION)105
11LANCETS MARKET, BY REGION106
11.1INTRODUCTION107
TABLE 42LANCETS MARKET, BY REGION, 2021–2028 (USD MILLION)107
11.2NORTH AMERICA107
11.2.1NORTH AMERICA: IMPACT OF RECESSION107
FIGURE 33NORTH AMERICA: LANCETS MARKET SNAPSHOT108
TABLE 43NORTH AMERICA: LANCETS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)108
TABLE 44NORTH AMERICA: LANCETS MARKET, BY TYPE, 2021–2028 (USD MILLION)109
TABLE 45NORTH AMERICA: SAFETY LANCETS MARKET, BY TYPE, 2021–2028 (USD MILLION)109
TABLE 46NORTH AMERICA: MANUALLY ACTIVATED LANCETS MARKET, BY TYPE, 2021–2028 (USD MILLION)109
TABLE 47NORTH AMERICA: LANCETS MARKET, BY GAUGE SIZE, 2021–2028 (USD MILLION)109
TABLE 48NORTH AMERICA: LANCETS MARKET, BY AGE GROUP, 2021–2028 (USD MILLION)110
TABLE 49NORTH AMERICA: LANCETS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)110
TABLE 50NORTH AMERICA: LANCETS MARKET, BY END USER, 2021–2028 (USD MILLION)110
11.2.2US111
11.2.2.1Increasing incidence and prevalence of lifestyle diseases to drive market111
TABLE 51US: LANCETS MARKET, BY TYPE, 2021–2028 (USD MILLION)111
TABLE 52US: SAFETY LANCETS MARKET, BY TYPE, 2021–2028 (USD MILLION)111
TABLE 53US: MANUALLY ACTIVATED LANCETS MARKET, BY TYPE, 2021–2028 (USD MILLION)112
TABLE 54US: LANCETS MARKET, BY GAUGE SIZE, 2021–2028 (USD MILLION)112
TABLE 55US: LANCETS MARKET, BY AGE GROUP, 2021–2028 (USD MILLION)112
TABLE 56US: LANCETS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)113
TABLE 57US: LANCETS MARKET, BY END USER, 2021–2028 (USD MILLION)113
11.2.3CANADA113
11.2.3.1Rising incidence of allergies to drive market113
TABLE 58CANADA: LANCETS MARKET, BY TYPE, 2021–2028 (USD MILLION)114
TABLE 59CANADA: SAFETY LANCETS MARKET, BY TYPE, 2021–2028 (USD MILLION)114
TABLE 60CANADA: MANUALLY ACTIVATED LANCETS MARKET, BY TYPE, 2021–2028 (USD MILLION)114
TABLE 61CANADA: LANCETS MARKET, BY GAUGE SIZE, 2021–2028 (USD MILLION)115
TABLE 62CANADA: LANCETS MARKET, BY AGE GROUP, 2021–2028 (USD MILLION)115
TABLE 63CANADA: LANCETS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)115
TABLE 64CANADA: LANCETS MARKET, BY END USER, 2021–2028 (USD MILLION)116
11.3EUROPE116
11.3.1EUROPE: IMPACT OF RECESSION116
TABLE 65EUROPE: LANCETS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)117
TABLE 66EUROPE: LANCETS MARKET, BY TYPE, 2021–2028 (USD MILLION)117
TABLE 67EUROPE: SAFETY LANCETS MARKET, BY TYPE, 2021–2028 (USD MILLION)117
TABLE 68EUROPE: MANUALLY ACTIVATED LANCETS MARKET, BY TYPE, 2021–2028 (USD MILLION)118
TABLE 69EUROPE: LANCETS MARKET, BY GAUGE SIZE, 2021–2028 (USD MILLION)118
TABLE 70EUROPE: LANCETS MARKET, BY AGE GROUP, 2021–2028 (USD MILLION)118
TABLE 71EUROPE: LANCETS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)119
TABLE 72EUROPE: LANCETS MARKET, BY END USER, 2021–2028 (USD MILLION)119
11.3.2GERMANY119
11.3.2.1Germany to dominate European lancets market119
TABLE 73GERMANY: LANCETS MARKET, BY TYPE, 2021–2028 (USD MILLION)120
TABLE 74GERMANY: SAFETY LANCETS MARKET, BY TYPE, 2021–2028 (USD MILLION)120
TABLE 75GERMANY: MANUALLY ACTIVATED LANCETS MARKET, BY TYPE, 2021–2028 (USD MILLION)120
TABLE 76GERMANY: LANCETS MARKET, BY GAUGE SIZE, 2021–2028 (USD MILLION)121
TABLE 77GERMANY: LANCETS MARKET, BY AGE GROUP, 2021–2028 (USD MILLION)121
TABLE 78GERMANY: LANCETS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)121
TABLE 79GERMANY: LANCETS MARKET, BY END USER, 2021–2028 (USD MILLION)122
11.3.3FRANCE122
11.3.3.1Growing public-private collaborations for product development to support market growth122
TABLE 80FRANCE: LANCETS MARKET, BY TYPE, 2021–2028 (USD MILLION)122
TABLE 81FRANCE: SAFETY LANCETS MARKET, BY TYPE, 2021–2028 (USD MILLION)123
TABLE 82FRANCE: MANUALLY ACTIVATED LANCETS MARKET, BY TYPE, 2021–2028 (USD MILLION)123
TABLE 83FRANCE: LANCETS MARKET, BY GAUGE SIZE, 2021–2028 (USD MILLION)123
TABLE 84FRANCE: LANCETS MARKET, BY AGE GROUP, 2021–2028 (USD MILLION)123
TABLE 85FRANCE: LANCETS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)124
TABLE 86FRANCE: LANCETS MARKET, BY END USER, 2021–2028 (USD MILLION)124
11.3.4UK124
11.3.4.1Increasing prevalence of lifestyle diseases to drive market124
TABLE 87UK: LANCETS MARKET, BY TYPE, 2021–2028 (USD MILLION)125
TABLE 88UK: SAFETY LANCETS MARKET, BY TYPE, 2021–2028 (USD MILLION)125
TABLE 89UK: MANUALLY ACTIVATED LANCETS MARKET, BY TYPE, 2021–2028 (USD MILLION)125
TABLE 90UK LANCETS MARKET, BY GAUGE SIZE, 2021–2028 (USD MILLION)126
TABLE 91UK: LANCETS MARKET, BY AGE GROUP, 2021–2028 (USD MILLION)126
TABLE 92UK: LANCETS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)126
TABLE 93UK: LANCETS MARKET, BY END USER, 2021–2028 (USD MILLION)127
11.3.5ITALY127
11.3.5.1Slower growth in healthcare sector to restrain market growth127
TABLE 94ITALY: LANCETS MARKET, BY TYPE, 2021–2028 (USD MILLION)127
TABLE 95ITALY: SAFETY LANCETS MARKET, BY TYPE, 2021–2028 (USD MILLION)128
TABLE 96ITALY: MANUALLY ACTIVATED LANCETS MARKET, BY TYPE, 2021–2028 (USD MILLION)128
TABLE 97ITALY: LANCETS MARKET, BY GAUGE SIZE, 2021–2028 (USD MILLION)128
TABLE 98ITALY: LANCETS MARKET, BY AGE GROUP, 2021–2028 (USD MILLION)128
TABLE 99ITALY: LANCETS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)129
TABLE 100ITALY: LANCETS MARKET, BY END USER, 2021–2028 (USD MILLION)129
11.3.6SPAIN129
11.3.6.1Increasing funding for research to boost market growth129
TABLE 101SPAIN: LANCETS MARKET, BY TYPE, 2021–2028 (USD MILLION)130
TABLE 102SPAIN: SAFETY LANCETS MARKET, BY TYPE, 2021–2028 (USD MILLION)130
TABLE 103SPAIN: MANUALLY ACTIVATED LANCETS MARKET, BY TYPE, 2021–2028 (USD MILLION)130
TABLE 104SPAIN: LANCETS MARKET, BY GAUGE SIZE, 2021–2028 (USD MILLION)131
TABLE 105SPAIN: LANCETS MARKET, BY AGE GROUP, 2021–2028 (USD MILLION)131
TABLE 106SPAIN: LANCETS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)131
TABLE 107SPAIN: LANCETS MARKET, BY END USER, 2021–2028 (USD MILLION)132
11.3.7REST OF EUROPE132
TABLE 108REST OF EUROPE: LANCETS MARKET, BY TYPE, 2021–2028 (USD MILLION)132
TABLE 109REST OF EUROPE: SAFETY LANCETS MARKET, BY TYPE, 2021–2028 (USD MILLION)133
TABLE 110REST OF EUROPE: MANUALLY ACTIVATED LANCETS MARKET, BY TYPE, 2021–2028 (USD MILLION)133
TABLE 111REST OF EUROPE: LANCETS MARKET, BY GAUGE SIZE, 2021–2028 (USD MILLION)133
TABLE 112REST OF EUROPE: LANCETS MARKET, BY AGE GROUP, 2021–2028 (USD MILLION)133
TABLE 113REST OF EUROPE: LANCETS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)134
TABLE 114REST OF EUROPE: LANCETS MARKET, BY END USER, 2021–2028 (USD MILLION)134
11.4ASIA PACIFIC134
11.4.1ASIA PACIFIC: IMPACT OF RECESSION135
FIGURE 34ASIA PACIFIC: LANCETS MARKET SNAPSHOT136
TABLE 115ASIA PACIFIC: LANCETS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)137
TABLE 116ASIA PACIFIC: LANCETS MARKET, BY TYPE, 2021–2028 (USD MILLION)137
TABLE 117ASIA PACIFIC: SAFETY LANCETS MARKET, BY TYPE, 2021–2028 (USD MILLION)137
TABLE 118ASIA PACIFIC: MANUALLY ACTIVATED LANCETS MARKET, BY TYPE, 2021–2028 (USD MILLION)138
TABLE 119ASIA PACIFIC: LANCETS MARKET, BY GAUGE SIZE, 2021–2028 (USD MILLION)138
TABLE 120ASIA PACIFIC: LANCETS MARKET, BY AGE GROUP, 2021–2028 (USD MILLION)138
TABLE 121ASIA PACIFIC: LANCETS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)139
TABLE 122ASIA PACIFIC: LANCETS MARKET, BY END USER, 2021–2028 (USD MILLION)139
11.4.2JAPAN139
11.4.2.1Well-established healthcare system to support market growth139
TABLE 123JAPAN: LANCETS MARKET, BY TYPE, 2021–2028 (USD MILLION)140
TABLE 124JAPAN: SAFETY LANCETS MARKET, BY TYPE, 2021–2028 (USD MILLION)140
TABLE 125JAPAN: MANUALLY ACTIVATED LANCETS MARKET, BY TYPE, 2021–2028 (USD MILLION)140
TABLE 126JAPAN: LANCETS MARKET, BY GAUGE SIZE, 2021–2028 (USD MILLION)141
TABLE 127JAPAN: LANCETS MARKET, BY AGE GROUP, 2021–2028 (USD MILLION)141
TABLE 128JAPAN: LANCETS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)141
TABLE 129JAPAN: LANCETS MARKET, BY END USER, 2021–2028 (USD MILLION)142
11.4.3CHINA142
11.4.3.1Fastest-growing market for lancets142
TABLE 130CHINA: LANCETS MARKET, BY TYPE, 2021–2028 (USD MILLION)143
TABLE 131CHINA: SAFETY LANCETS MARKET, BY TYPE, 2021–2028 (USD MILLION)143
TABLE 132CHINA: MANUALLY ACTIVATED LANCETS MARKET, BY TYPE, 2021–2028 (USD MILLION)143
TABLE 133CHINA: LANCETS MARKET, BY GAUGE SIZE, 2021–2028 (USD MILLION)143
TABLE 134CHINA: LANCETS MARKET, BY AGE GROUP, 2021–2028 (USD MILLION)144
TABLE 135CHINA: LANCETS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)144
TABLE 136CHINA: LANCETS MARKET, BY END USER, 2021–2028 (USD MILLION)144
11.4.4INDIA145
11.4.4.1High burden of chronic diseases to support market growth145
TABLE 137INDIA: LANCETS MARKET, BY TYPE, 2021–2028 (USD MILLION)145
TABLE 138INDIA: SAFETY LANCETS MARKET, BY TYPE, 2021–2028 (USD MILLION)146
TABLE 139INDIA: MANUALLY ACTIVATED LANCETS MARKET, BY TYPE, 2021–2028 (USD MILLION)146
TABLE 140INDIA: LANCETS MARKET, BY GAUGE SIZE, 2021–2028 (USD MILLION)146
TABLE 141INDIA: LANCETS MARKET, BY AGE GROUP, 2021–2028 (USD MILLION)146
TABLE 142INDIA: LANCETS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)147
TABLE 143INDIA: LANCETS MARKET, BY END USER, 2021–2028 (USD MILLION)147
11.4.5SOUTH KOREA147
11.4.5.1Increasing government initiatives to aid market growth147
TABLE 144SOUTH KOREA: LANCETS MARKET, BY TYPE, 2021–2028 (USD MILLION)148
TABLE 145SOUTH KOREA: SAFETY LANCETS MARKET, BY TYPE, 2021–2028 (USD MILLION)148
TABLE 146SOUTH KOREA: MANUALLY ACTIVATED LANCETS MARKET, BY TYPE, 2021–2028 (USD MILLION)148
TABLE 147SOUTH KOREA: LANCETS MARKET, BY GAUGE SIZE, 2021–2028 (USD MILLION)148
TABLE 148SOUTH KOREA: LANCETS MARKET, BY AGE GROUP, 2021–2028 (USD MILLION)149
TABLE 149SOUTH KOREA: LANCETS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)149
TABLE 150SOUTH KOREA: LANCETS MARKET, BY END USER, 2021–2028 (USD MILLION)149
11.4.6REST OF ASIA PACIFIC150
TABLE 151REST OF ASIA PACIFIC: LANCETS MARKET, BY TYPE, 2021–2028 (USD MILLION)150
TABLE 152REST OF ASIA PACIFIC: SAFETY LANCETS MARKET, BY TYPE, 2021–2028 (USD MILLION)150
TABLE 153REST OF ASIA PACIFIC: MANUALLY ACTIVATED LANCETS MARKET, BY TYPE, 2021–2028 (USD MILLION)150
TABLE 154REST OF ASIA PACIFIC: LANCETS MARKET, BY GAUGE SIZE, 2021–2028 (USD MILLION)151
TABLE 155REST OF ASIA PACIFIC: LANCETS MARKET, BY AGE GROUP, 2021–2028 (USD MILLION)151
TABLE 156REST OF ASIA PACIFIC: LANCETS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)151
TABLE 157REST OF ASIA PACIFIC: LANCETS MARKET, BY END USER, 2021–2028 (USD MILLION)152
11.5REST OF THE WORLD152
TABLE 158REST OF THE WORLD: LANCETS MARKET, BY REGION, 2021–2028 (USD MILLION)152
TABLE 159REST OF THE WORLD: LANCETS MARKET, BY TYPE, 2021–2028 (USD MILLION)152
TABLE 160REST OF THE WORLD: SAFETY LANCETS MARKET, BY TYPE, 2021–2028 (USD MILLION)153
TABLE 161REST OF THE WORLD: MANUALLY ACTIVATED LANCETS MARKET, BY TYPE, 2021–2028 (USD MILLION)153
TABLE 162REST OF THE WORLD: LANCETS MARKET, BY GAUGE SIZE, 2021–2028 (USD MILLION)153
TABLE 163REST OF THE WORLD: LANCETS MARKET, BY AGE GROUP, 2021–2028 (USD MILLION)153
TABLE 164REST OF THE WORLD: LANCETS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)154
TABLE 165REST OF THE WORLD: LANCETS MARKET, BY END USER, 2021–2028 (USD MILLION)154
11.5.1LATIN AMERICA154
11.5.1.1Rising prevalence of diabetes and cancer to support market growth154
11.5.1.2Latin America: Impact of recession155
TABLE 166LATIN AMERICA: LANCETS MARKET, BY TYPE, 2021–2028 (USD MILLION)155
TABLE 167LATIN AMERICA: SAFETY LANCETS MARKET, BY TYPE, 2021–2028 (USD MILLION)156
TABLE 168LATIN AMERICA: MANUALLY ACTIVATED LANCETS MARKET, BY TYPE, 2021–2028 (USD MILLION)156
TABLE 169LATIN AMERICA: LANCETS MARKET, BY GAUGE SIZE, 2021–2028 (USD MILLION)156
TABLE 170LATIN AMERICA: LANCETS MARKET, BY AGE GROUP, 2021–2028 (USD MILLION)156
TABLE 171LATIN AMERICA: LANCETS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)157
TABLE 172LATIN AMERICA: LANCETS MARKET, BY END USER, 2021–2028 (USD MILLION)157
11.5.2MIDDLE EAST AND AFRICA157
11.5.2.1Rising geriatric population and increasing prevalence of chronic diseases to drive market157
11.5.2.2Middle East & Africa: Impact of recession158
TABLE 173MIDDLE EAST AND AFRICA: LANCETS MARKET, BY TYPE, 2021–2028 (USD MILLION)159
TABLE 174MIDDLE EAST AND AFRICA: SAFETY LANCETS MARKET, BY TYPE, 2021–2028 (USD MILLION)159
TABLE 175MIDDLE EAST AND AFRICA: MANUALLY ACTIVATED LANCETS MARKET, BY TYPE, 2021–2028 (USD MILLION)159
TABLE 176MIDDLE EAST AND AFRICA: LANCETS MARKET, BY GAUGE SIZE, 2021–2028 (USD MILLION)160
TABLE 177MIDDLE EAST AND AFRICA: LANCETS MARKET, BY AGE GROUP, 2021–2028 (USD MILLION)160
TABLE 178MIDDLE EAST AND AFRICA: LANCETS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)160
TABLE 179MIDDLE EAST AND AFRICA: LANCETS MARKET, BY END USER, 2021–2028 (USD MILLION)161
12COMPETITIVE LANDSCAPE162
12.1OVERVIEW162
TABLE 180OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN LANCETS MARKET162
12.2REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS163
FIGURE 35REVENUE SHARE ANALYSIS OF TOP PLAYERS IN LANCETS MARKET163
12.3MARKET SHARE ANALYSIS164
TABLE 181LANCETS MARKET: DEGREE OF COMPETITION164
12.4COMPETITIVE LEADERSHIP MAPPING164
12.4.1STARS165
12.4.2EMERGING LEADERS165
12.4.3PERVASIVE PLAYERS165
12.4.4PARTICIPANTS165
FIGURE 36LANCETS MARKET: COMPANY EVALUATION QUADRANT FOR KEY PLAYERS, 2022166
12.5COMPANY EVALUATION QUADRANT FOR SMES/STARTUPS167
12.5.1PROGRESSIVE COMPANIES167
12.5.2STARTING BLOCKS167
12.5.3RESPONSIVE COMPANIES167
12.5.4DYNAMIC COMPANIES167
FIGURE 37LANCETS MARKET: COMPANY EVALUATION MATRIX FOR SMES/STARTUPS, 2022168
12.6COMPETITIVE BENCHMARKING169
TABLE 182LANCETS MARKET: DETAILED LIST OF KEY STARTUPS/SMES169
12.7COMPANY FOOTPRINT ANALYSIS170
TABLE 183FOOTPRINT ANALYSIS OF COMPANIES170
TABLE 184REGIONAL FOOTPRINT ANALYSIS OF COMPANIES171
TABLE 185PRODUCT FOOTPRINT ANALYSIS OF COMPANIES172
12.8COMPETITIVE SCENARIO173
12.8.1PRODUCT LAUNCHES173
TABLE 186KEY PRODUCT LAUNCHES, JANUARY 2020–MAY 2023173
12.8.2DEALS173
TABLE 187KEY DEALS, JANUARY 2020–MAY 2023173
12.8.3OTHER DEVELOPMENTS174
TABLE 188OTHER KEY DEVELOPMENTS, JANUARY 2020–MAY 2023174
13COMPANY PROFILES175
13.1KEY PLAYERS175
(Business overview, Products offered, Recent Developments, MNM view)*
13.1.1BECTON, DICKINSON AND COMPANY175
TABLE 189BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW175
FIGURE 38BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2022)176
13.1.2F. HOFFMANN-LA ROCHE LTD.178
TABLE 190F. HOFFMANN-LA ROCHE LTD.: BUSINESS OVERVIEW178
FIGURE 39F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2022)179
13.1.3YPSOMED182
TABLE 191YPSOMED: BUSINESS OVERVIEW182
FIGURE 40YPSOMED: COMPANY SNAPSHOT (2022)183
13.1.4B. BRAUN SE185
TABLE 192B. BRAUN SE: BUSINESS OVERVIEW185
FIGURE 41B. BRAUN SE: COMPANY SNAPSHOT (2022)186
13.1.5TERUMO CORPORATION188
TABLE 193TERUMO CORPORATION: BUSINESS OVERVIEW188
FIGURE 42TERUMO CORPORATION: COMPANY SNAPSHOT (2022)189
13.1.6GREINER BIO-ONE INTERNATIONAL GMBH191
TABLE 194GREINER BIO-ONE INTERNATIONAL GMBH: BUSINESS OVERVIEW191
FIGURE 43GREINER BIO-ONE INTERNATIONAL GMBH: COMPANY SNAPSHOT (2021)192
13.1.7ABBOTT LABORATORIES194
TABLE 195ABBOTT LABORATORIES: BUSINESS OVERVIEW194
FIGURE 44ABBOTT LABORATORIES: COMPANY SNAPSHOT (2022)195
13.1.8OWEN MUMFORD196
TABLE 196OWEN MUMFORD: BUSINESS OVERVIEW196
13.1.9HTL-STREFA S.A.198
TABLE 197HTL-STREFA S.A.: BUSINESS OVERVIEW198
13.1.10ARKRAY, INC.199
TABLE 198ARKRAY, INC.: BUSINESS OVERVIEW199
13.1.11SARSTEDT AG & CO. KG200
TABLE 199SARSTEDT AG & CO. KG: BUSINESS OVERVIEW200
13.1.12STERILANCE MEDICAL (SUZHOU) INC.201
TABLE 200STERILANCE MEDICAL (SUZHOU): BUSINESS OVERVIEW201
13.1.13MEDLINE INDUSTRIES203
TABLE 201MEDLINE INDUSTRIES: BUSINESS OVERVIEW203
13.1.14AGAMATRIX, INC.204
TABLE 202AGAMATRIX, INC.: BUSINESS OVERVIEW204
13.1.15ACON LABORATORIES, INC.205
TABLE 203ACON LABORATORIES, INC.: BUSINESS OVERVIEW205
13.1.16SANLI MEDICAL & HEALTH SERVICE206
TABLE 204SANLI MEDICAL & HEALTH SERVICE: BUSINESS OVERVIEW206
13.1.17ALLISON MEDICAL, INC.207
TABLE 205ALLISON MEDICAL, INC.: BUSINESS OVERVIEW207
13.1.18GLUCORX LIMITED208
TABLE 206GLUCORX LIMITED: BUSINESS OVERVIEW208
*Details on Business overview, Products offered, Recent Developments, MNM view might not be captured in case of unlisted companies.
 
13.2OTHER PLAYERS209
13.2.1FL MEDICAL S.R.L209
13.2.2MHC MEDICAL PRODUCTS, LLC209
13.2.3NEOMEDIC210
13.2.4CML BIOTECH LTD.210
13.2.5DISERA TIBBI MALZEME LOJISTIK SANAYI VE TICARET A.Ş.211
13.2.6A. MENARINI DIAGNOSTICS S.R.L211
14APPENDIX212
14.1DISCUSSION GUIDE212
14.2KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL216
14.3CUSTOMIZATION OPTIONS218
14.4RELATED REPORTS218
14.5AUTHOR DETAILS219